The development of psychotic disorders in adolescence: A potential role for hormones

Hormones and Behavior

Volumn 64, Issue 2, 2013, Pages 411-419

  Trotman, Hanan D ^a   Holtzman, Carrie W ^a   Ryan, Arthur T ^a   Shapiro, Daniel I ^a   MacDonald, Allison N ^a   Goulding, Sandra M ^a   Brasfield, Joy L ^a   Walker, Elaine F ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Adolescence; Brain development; Hypothalamic pituitary adrenal HPA axis; Hypothalamic pituitary gonadal HPG axis; Prodrome; Psychosis; Puberty

Indexed keywords

ADRENAL GLAND HORMONE; SEX HORMONE; STEROID HORMONE; UNCLASSIFIED DRUG;

ADOLESCENCE; ADOLESCENT DEVELOPMENT; ADULTHOOD; BRAIN DEVELOPMENT; DISEASE COURSE; HIGH RISK POPULATION; HORMONE ACTION; HUMAN; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PRODROMAL STAGE; PSYCHOSIS; PUBERTY; REVIEW; SCHIZOPHRENIA;

ADOLESCENCE; BRAIN DEVELOPMENT; HYPOTHALAMIC-PITUITARY-ADRENAL [HPA] AXIS; HYPOTHALAMIC-PITUITARY-GONADAL [HPG] AXIS; PRODROME; PSYCHOSIS; PUBERTY;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ADOLESCENT PSYCHOLOGY; ADRENAL GLANDS; BRAIN; GONADAL HORMONES; HORMONES; HUMANS; PRODROMAL SYMPTOMS; PSYCHOTIC DISORDERS; SEXUAL MATURATION;

EID: 84883418075     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2013.02.018     Document Type: Review

References (162)

1. Adam E.K. Transactions among adolescent trait and state emotion and diurnal and momentary cortisol activity in naturalistic settings. Psychoneuroendocrinology 2006, 31:664-679.
2. Adams J., Barone S., LaMantia A., Philen R., Rice D.C., Spear L., Susser E. Workshop to identify critical windows of exposure for children's health: neurobehavioral work group summary. Environ. Health Perspect. 2000, 108(Suppl. 3):535-544.
3. Addington J. The prodromal stage of psychotic illness: observation, detection or intervention?. J. Psychiatry Neurosci. 2003, 28:93-97.
4. Addington J., Cadenhead K., Cannon T., Cornblatt B., McGlashan T., Perkins D., Seidman L., Tsuang M., Walker E., Woods S., Heinssen R., Study, N.A.P.L. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr. Bull. 2007, 33:665-672.
5. Adriano F., Caltagirone C., Spalletta G. Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis. Neuroscientist 2012, 18:180-200.
6. Ang Y., Tan H. Academic deterioration prior to first episode schizophrenia in young Singaporean males. Psychiatry Res. 2004, 121:303-307.
7. Arad M., Weiner I. Disruption of latent inhibition induced by ovariectomy can be reversed by estradiol and clozapine as well as by co-administration of haloperidol with estradiol but not by haloperidol alone. Psychopharmacology (Berl) 2009, 206:731-740.
8. Arad M., Weiner I. Abnormally rapid reversal learning and reduced response to antipsychotic drugs following ovariectomy in female rats. Psychoneuroendocrinology 2012, 37:200-212.
9. Arnold A.P., Breedlove S.M. Organizational and activational effects of sex steroids on brain and behavior: a reanalysis. Horm. Behav. 1985, 19:469-498.
10. Arnone D., Cavanagh J., Gerber D., Lawrie S.M., Ebmeier K.P., McIntosh A.M. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br. J. Psychiatry 2009, 195:194-201.
11. Arnsten A.F. Stress signalling pathways that impair prefrontal cortex structure and function. Nat. Rev. Neurosci. 2009, 10:410-422.
12. Asato M.R., Terwilliger R., Woo J., Luna B. White matter development in adolescence: a DTI study. Cereb. Cortex 2010, 20:2122-2131.
13. Benes F.M. Why does psychosis develop during adolescence and early adulthood?. Curr. Opin. Psychiatry 2003, 16:317-319.
14. Blakemore S.J. Imaging brain development: the adolescent brain. Neuroimage 2012, 61:397-406.
15. Borgwardt S.J., Picchioni M.M., Ettinger U., Toulopoulou T., Murray R., McGuire P.K. Regional gray matter volume in monozygotic twins concordant and discordant for schizophrenia. Biol. Psychiatry 2010, 67:956-964.
16. Bramen J.E., Hranilovich J.A., Dahl R.E., Forbes E.E., Chen J., Toga A.W., Dinov I.D., Worthman C.M., Sowell E.R. Puberty influences medial temporal lobe and cortical gray matter maturation differently in boys than girls matched for sexual maturity. Cereb. Cortex 2011, 21:636-646.
17. Brennan P.A., Walker E.F. Vulnerability to schizophrenia risk factors in childhood and adolescence. Vulnerability to Psychopathology: Risk Across the Lifespan 2001, 476. The Guilford Press, New York. R.E. Ingram, J.M. Price (Eds.).
18. Brook C.G. Mechanism of puberty. Horm. Res. 1999, 51(Suppl. 3):52-54.
19. Brown, G.R., Spencer, K.A., in press. Steroid hormones, stress and the adolescent brain: a comparative perspective. Neuroscience.
20. Buka S.L., Fan A.P. Association of prenatal and perinatal complications with subsequent bipolar disorder and schizophrenia. Schizophr. Res. 1999, 39:113-119. (discussion 160-111).
21. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., Seidman L.J., Perkins D., Tsuang M., McGlashan T., Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry 2008, 65:28-37.
22. Carey M.P., Deterd C.H., de Koning J., Helmerhorst F., de Kloet E.R. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J. Endocrinol. 1995, 144:311-321.
23. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988, 1:179-186.
24. Cashion A.B., Smith M.J., Wise P.M. The morphometry of astrocytes in the rostral preoptic area exhibits a diurnal rhythm on proestrus: relationship to the luteinizing hormone surge and effects of age. Endocrinology 2003, 144:274-280.
25. Castro-Fornieles J., Bargallo N., Lazaro L., Andres S., Falcon C., Plana M.T., Junque C. A cross-sectional and follow-up voxel-based morphometric MRI study in adolescent anorexia nervosa. J. Psychiatr. Res. 2009, 43:331-340.
26. Chana L.F., Vaidyab M., Westphalc B., Allgrovea J., Martina L., Afshard F., Hindmarshf P.C., Savagea M.O., Grossmane A.B., Storra H.L. Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease. Horm. Res. Paediatr. 2011, 75:441-446.
27. Charmandari E., Kino T., Souvatzoglou E., Chrousos G. Pediatric stress: hormonal mediators and human development. Horm. Res. 2003, 59:161-179.
28. Chavez C., Hollaus M., Scarr E., Pavey G., Gogos A., van den Buuse M. The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study. Brain Res. 2010, 1321:51-59.
29. Collip D., Nicolson N.A., Lardinois M., Lataster T., van Os J., Myin-Germeys I. Daily cortisol, stress reactivity and psychotic experiences in individuals at above average genetic risk for psychosis. Psychol. Med. 2011, 41:2305-2315.
30. Compton M.T., McGlashan T.H., McGorry P.D. Toward prevention approaches for schizophrenia: an overview of prodromal states, the duration of untreated psychosis, and early intervention paradigms. Psychiatr. Ann. 2007, 37:340-348.
31. Correll C.U., Hauser M., Auther A.M., Cornblatt B.A. Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J. Child Psychol. Psychiatry 2010, 51:390-431.
32. Craddock N., O'Donovan M.C., Owen M.J. Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or "schizoaffective") psychoses. Schizophr. Bull. 2009, 35:482-490.
33. Davidson L.L., Heinrichs R.W. Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis. Psychiatry Res. 2003, 122:69-87.
34. De Bellis M.D., Keshavan M.S., Beers S.R., Hall J., Frustaci K., Masalehdan A., Noll J., Boring A.M. Sex differences in brain maturation during childhood and adolescence. Cereb. Cortex 2001, 11:552-557.
35. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision 2000, American Psychiatric Association, Arlington, VA. 4th ed.
36. Dorn L.D., Biro F.M. Puberty and its measurement: a decade in review. J. Res. Adolesc. 2011, 21:180-195.
37. Dorn L.D., Dahl R.E., Woodward H.R., Biro F. Defining the boundaries of early adolescence: a user's guide to assessing pubertal status and pubertal timing in research with adolescents. Appl. Dev. Sci. 2006, 10:30-56.
38. Douaud G., Mackay C., Andersson J., James S., Quested D., Ray M.K., Connell J., Roberts N., Crow T.J., Matthews P.M., Smith S., James A. Schizophrenia delays and alters maturation of the brain in adolescence. Brain 2009, 132:2437-2448.
39. Drake R., Haley C., Akhtar S., Lewis S. Causes and consequences of duration of untreated psychosis in schizophrenia. Br. J. Psychiatry 2000, 177:511-515.
40. Dumitriu D., Rapp P.R., McEwen B.S., Morrison J.H. Estrogen and the aging brain: an elixir for the weary cortical network. Ann. N. Y. Acad. Sci. 2010, 1204:104-112.
41. Ellis B.J., Shirtcliff E.A., Boyce W.T., Deardorff J., Essex M.J. Quality of early family relationships and the timing and tempo of puberty: effects depend on biological sensitivity to context. Dev. Psychopathol. 2011, 23:85-99.
42. Epstein J., Stern E., Silbersweig D. Mesolimbic activity associated with psychosis in schizophrenia. Symptom-specific PET studies. Ann. N. Y. Acad. Sci. 1999, 877:562-574.
43. Falkenstein E., Tillmann H.C., Christ M., Feuring M., Wehling M. Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacol. Rev. 2000, 52:513-556.
44. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. J. Psychiatr. Res. 1982, 17:319-334.
45. Fernandez-Egea E., Garcia-Rizo C., Miller B., Parellada E., Justicia A., Bernardo M., Kirkpatrick B. Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesis. Psychosom. Med. 2011, 73:643-647.
46. Foilb A.R., Lui P., Romeo R.D. The transformation of hormonal stress responses throughout puberty and adolescence. J. Endocrinol. 2011, 210:391-398.
47. Frodl T., O'Keane V. How does the brain deal with cumulative stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans. Neurobiol. Dis. 2013, 52:24-37.
48. Fuller R., Nopoulos P., Arndt S., O'Leary D., Ho B., Andreasen N. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am. J. Psychiatry 2002, 159:1183-1189.
49. Fusar-Poli P., Borgwardt S., Crescini A., Deste G., Kempton M.J., Lawrie S., Mc Guire P., Sacchetti E. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci. Biobehav. Rev. 2011, 35:1175-1185.
50. Garner B., Pariante C.M., Wood S.J., Velakoulis D., Phillips L., Soulsby B., Brewer W.J., Smith D.J., Dazzan P., Berger G.E., Yung A.R., van den Buuse M., Murray R., McGorry P.D., Pantelis C. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol. Psychiatry 2005, 58:417-423.
51. Garner B., Phassouliotis C., Phillips L.J., Markulev C., Butselaar F., Bendall S., Yun Y., McGorry P.D. Cortisol and dehydroepiandrosterone-sulphate levels correlate with symptom severity in first-episode psychosis. J. Psychiatr. Res. 2011, 45:249-255.
52. Gatzke-Kopp L.M. The canary in the coalmine: the sensitivity of mesolimbic dopamine to environmental adversity during development. Neurosci. Biobehav. Rev. 2011, 35:794-803.
53. Geller B., Zimerman B., Williams M., Bolhofner K., Craney J.L., Delbello M.P., Soutullo C.A. Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 2000, 10:157-164.
54. Giedd J.N. Structural magnetic resonance imaging of the adolescent brain. Ann. N. Y. Acad. Sci. 2004, 1021:77-85.
55. Giedd J.N., Vaituzis A.C., Hamburger S.D., Lange N., Rajapakse J.C., Kaysen D., Vauss Y.C., Rapoport J.L. Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: ages 4-18years. J. Comp. Neurol. 1996, 366:223-230.
56. Giedd J.N., Blumenthal J., Jeffries N.O., Castellanos F.X., Liu H., Zijdenbos A., Paus T., Evans A.C., Rapoport J.L. Brain development during childhood and adolescence: a longitudinal MRI study. Nat. Neurosci. 1999, 2:861-863.
57. Golub M.S., Collman G.W., Foster P.M., Kimmel C.A., Rajpert-De Meyts E., Reiter E.O., Sharpe R.M., Skakkebaek N.E., Toppari J. Public health implications of altered puberty timing. Pediatrics 2008, 121(Suppl. 3):S218-S230.
58. Gottesman I. Schizophrenia Genesis: The Origins of Madness 1991.
59. Graber J.A., Lewinsohn P.M., Seeley J.R., Brooks-Gunn J. Is psychopathology associated with the timing of pubertal development?. J. Am. Acad. Child Adolesc. Psychiatry 1997, 36:1768-1776.
60. Greenblatt D.J., Harmatz J.S., Shader R.I. Psychotropic drug prescribing in the United States: extent, costs, and expenditures. J. Clin. Psychopharmacol. 2011, 31:1-3.
61. Groeneweg F.L., Karst H., de Kloet E.R., Joels M. Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling. Mol. Cell. Endocrinol. 2012, 350:299-309.
62. Guerriero G. Vertebrate sex steroid receptors: evolution, ligands, and neurodistribution. Ann. N. Y. Acad. Sci. 2009, 1163:154-168.
63. Guest P.C., Martins-de-Souza D., Vanattou-Saifoudine N., Harris L.W., Bahn S. Abnormalities in metabolism and hypothalamic-pituitary-adrenal axis function in schizophrenia. Int. Rev. Neurobiol. 2011, 101:145-168.
64. Gunnar M.R., Wewerka S., Frenn K., Long J.D., Griggs C. Developmental changes in hypothalamus-pituitary-adrenal activity over the transition to adolescence: normative changes and associations with puberty. Dev. Psychopathol. 2009, 21:69-85.
65. Hans S.L., Auerbach J.G., Styr B., Marcus J. Offspring of parents with schizophrenia: mental disorders during childhood and adolescence. Schizophr. Bull. 2004, 30:303-315.
66. Hayes E., Gavrilidis E., Kulkarni J. The role of oestrogen and other hormones in the pathophysiology and treatment of schizophrenia. Schizophr. Res. Treat. 2012, 2012:540273.
67. Herting M.M., Maxwell E.C., Irvine C., Nagel B.J. The Impact of sex, puberty, and hormones on white matter microstructure in adolescents. Cereb. Cortex 2011, 22:1979-1992.
68. Hill S.K., Schuepbach D., Herbener E.S., Keshavan M.S., Sweeney J.A. Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naive patients with schizophrenia. Schizophr. Res. 2004, 68:49-63.
69. Hiller-Sturmhofel S., Bartke A. The endocrine system: an overview. Alcohol Health Res. World 1998, 22:153-164.
70. Holtzman, C.W., Trotman, H.D., Goulding, S.M., Ryan, A.T., McDonald, A.N., Shapiro, D.I., Brasfield, J.L., Walker, E.F., in press. Stress and neurodevelopmental processes in the emergence of psychosis. Neuroscience.
71. Howes O., Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr. Bull. 2009, 35:549-562.
72. Hulshoff Pol H.E., Kahn R.S. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr. Bull. 2008, 34:354-366.
73. Johannessen J.O., McGlashan T.H., Larsen T.K., Horneland M., Joa I., Mardal S., Kvebaek R., Friis S., Melle I., Opjordsmoen S., Simonsen E., Ulrik H., Vaglum P. Early detection strategies for untreated first-episode psychosis. Schizophr. Res. 2001, 51:39-46.
74. Kendler K.S., Gardner C.O. The risk for psychiatric disorders in relatives of schizophrenic and control probands: a comparison of three independent studies. Psychol. Med. 1997, 27:411-419.
75. Kenny F.M., Gancayco G.P., Heald F.P., Hung W. Cortisol production rate in adolescent males in different stages of sexual maturation. J. Clin. Endocrinol. Metab. 1966, 26:1232-1236.
76. Kerdelhue B., Brown S., Lenoir V., Queenan J.T., Jones G.S., Scholler R., Jones H.W. Timing of initiation of the preovulatory luteinizing hormone surge and its relationship with the circadian cortisol rhythm in the human. Neuroendocrinology 2002, 75:158-163.
77. Keshavan M., Anderson S., Pettegrew J. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J. Psychiatr. Res. 1994, 28:239-265.
78. Keshavan M., Diwadkar V., Rosenberg D. Developmental biomarkers in schizophrenia and other psychiatric disorders: common origins, different trajectories?. Epidemiol. Psichiatr. Soc. 2005, 14:188-193.
79. Khaykin E., Eaton W.W., Ford D.E., Anthony C.B., Daumit G.L. Health insurance coverage among persons with schizophrenia in the United States. Psychiatr. Serv. 2010, 61:830-834.
80. Komatsuzaki Y., Hatanaka Y., Murakami G., Mukai H., Hojo Y., Saito M., Kimoto T., Kawato S. Corticosterone induces rapid spinogenesis via synaptic glucocorticoid receptors and kinase networks in hippocampus. PLoS One 2012, 7:e34124.
81. Kulkarni J., de Castella A., Headey B., Marston N., Sinclair K., Lee S., Gurvich C., Fitzgerald P.B., Burger H. Estrogens and men with schizophrenia: is there a case for adjunctive therapy?. Schizophr. Res. 2011, 125:278-283.
82. Ladouceur C.D., Peper J.S., Crone E.A., Dahl R.E. White matter development in adolescence: the influence of puberty and implications for affective disorders. Dev. Cogn. Neurosci. 2012, 2:36-54.
83. Lencz T., Smith C., Auther A., Correll C., Cornblatt B. Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophr. Res. 2004, 68:37-48.
84. Levitt J.J., Bobrow L., Lucia D., Srinivasan P. A selective review of volumetric and morphometric imaging in schizophrenia. Curr. Top. Behav. Neurosci. 2010, 4:243-281.
85. Luna B., Padmanabhan A., O'Hearn K. What has fMRI told us about the development of cognitive control through adolescence?. Brain Cogn. 2010, 72:101-113.
86. Lupien S.J., Wilkinson C.W., Briere S., Menard C., Ng Ying Kin N.M., Nair N.P. The modulatory effects of corticosteroids on cognition: studies in young human populations. Psychoneuroendocrinology 2002, 27:401-416.
87. Lyons D.M., Buckmaster P.S., Lee A.G., Wu C., Mitra R., Duffey L.M., Buckmaster C.L., Her S., Patel P.D., Schatzberg A.F. Stress coping stimulates hippocampal neurogenesis in adult monkeys. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:14823-14827.
88. Maccabe J.H. Population-based cohort studies on premorbid cognitive function in schizophrenia. Epidemiol. Rev. 2008, 30:77-83.
89. Marceau K., Ram N., Houts R.M., Grimm K.J., Susman E.J. Individual differences in boys' and girls' timing and tempo of puberty: modeling development with nonlinear growth models. Dev. Psychol. 2011, 47:1389-1409.
90. Markham J.A. Sex steroids and schizophrenia. Rev. Endocr. Metab. Disord. 2011, 13:187-207.
91. McEwen B.S. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 1991, 12:141-147.
92. McFarlane W.R. Prevention of the first episode of psychosis. Psychiatr. Clin. North Am. 2011, 34:95-107.
93. McGlashan T.H. Early detection and intervention in psychosis: an ethical paradigm shift. Br. J. Psychiatry Suppl. 2005, 48:s113-s115.
94. McGlashan T.H., Hoffman R.E. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch. Gen. Psychiatry 2000, 57:637-648.
95. McGlashan T.H., Miller T.J., Woods S.W. Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophr. Bull. 2001, 27:563-570.
96. Melcangi R.C., Panzica G., Garcia-Segura L.M. Neuroactive steroids: focus on human brain. Neuroscience 2011, 191:1-5.
97. Meltzer H., Stahl S. The dopamine hypothesis of schizophrenia: a review. Schizophr. Bull. 1976, 2:19-76.
98. Mendez P., Garcia-Segura L.M., Muller D. Estradiol promotes spine growth and synapse formation without affecting pre-established networks. Hippocampus 2011, 21:1263-1267.
99. Miller T., McGlashan T., Woods S., Stein K., Driesen N., Corcoran C., Hoffman R., Davidson L. Symptom assessment in schizophrenic prodromal states. Psychiatr. Q. 1999, 70:273-287.
100. Miller T., McGlashan T., Rosen J., Somjee L., Markovich P., Stein K., Woods S. Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive validity. Am. J. Psychiatry 2002, 159:863-865.
101. Mondelli V., Dazzan P., Gabilondo A., Tournikioti K., Walshe M., Marshall N., Schulze K.K., Murray R.M., McDonald C., Pariante C.M. Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 2008, 33:1004-1012.
102. Mondelli V., Pariante C.M., Navari S., Aas M., D'Albenzio A., Di Forti M., Handley R., Hepgul N., Marques T.R., Taylor H., Papadopoulos A.S., Aitchison K.J., Murray R.M., Dazzan P. Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis. Schizophr. Res. 2010, 119:75-78.
103. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328.
104. Murray C.J., Lopez A.D. Evidence-based health policy-lessons from the global burden of disease study. Science 1996, 274:740-743.
105. Murray R.M., McDonald C., Bramon E. Neurodevelopmental impairment, dopamine sensitisation, and social adversity in schizophrenia. World Psychiatry 2002, 1:137-145.
106. Pariante C.M., Vassilopoulou K., Velakoulis D., Phillips L., Soulsby B., Wood S.J., Brewer W., Smith D.J., Dazzan P., Yung A.R., Zervas I.M., Christodoulou G.N., Murray R., McGorry P.D., Pantelis C. Pituitary volume in psychosis. Br. J. Psychiatry 2004, 185:5-10.
107. Pariante C.M., Dazzan P., Danese A., Morgan K.D., Brudaglio F., Morgan C., Fearon P., Orr K., Hutchinson G., Pantelis C., Velakoulis D., Jones P.B., Leff J., Murray R.M. Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology 2005, 30:1923-1931.
108. Patacchioli F.R., Simeoni S., Monnazzi P., Pace M., Capri O., Perrone G. Menopause, mild psychological stress and salivary cortisol: influence of long-term hormone replacement therapy (HRT). Maturitas 2006, 55:150-155.
109. Peper J., Brouwer R., Schnack H., van Baal G., van Leeuwen M., van den Berg S., Delemarre-Van de Waal H., Boomsma D., Kahn R., Hulshoff Pol H. Sex steroids and brain structure in pubertal boys and girls. Psychoneuroendocrinology 2009, 34:332-342.
110. Peper J.S., Hulshoff Pol H.E., Crone E.A., van Honk J. Sex steroids and brain structure in pubertal boys and girls: a mini-review of neuroimaging studies. Neuroscience 2011, 191:28-37.
111. Peper J.S., van den Heuvel M.P., Mandl R.C., Pol H.E., van Honk J. Sex steroids and connectivity in the human brain: a review of neuroimaging studies. Psychoneuroendocrinology 2011, 36:1101-1113.
112. Puri B.K. Progressive structural brain changes in schizophrenia. Expert Rev. Neurother. 2010, 10:33-42.
113. Rapoport J.L., Giedd J.N., Blumenthal J., Hamburger S., Jeffries N., Fernandez T., Nicolson R., Bedwell J., Lenane M., Zijdenbos A., Paus T., Evans A. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry 1999, 56:649-654.
114. Redei E., Li L., Halasz I., McGivern R.F., Aird F. Fast glucocorticoid feedback inhibition of ACTH secretion in the ovariectomized rat: effect of chronic estrogen and progesterone. Neuroendocrinology 1994, 60:113-123.
115. Riecher-Rossler A., Kulkarni J. Estrogens and gonadal function in schizophrenia and related psychoses. Curr. Top. Behav. Neurosci. 2011, 8:155-171.
116. Romeo R.D. Adolescence: a central event in shaping stress reactivity. Dev. Psychobiol. 2010, 52:244-253.
117. Ross D.A., Cetas J.S. Steroid psychosis: a review for neurosurgeons. J. Neurooncol. 2012, 109:439-447.
118. Schoenfeld T.J., Gould E. Stress, stress hormones, and adult neurogenesis. Exp. Neurol. 2012, 233:12-21.
119. Schulz K., Molenda-Figueira H., Sisk C. Back to the future: the organizational-activational hypothesis adapted to puberty and adolescence. Horm. Behav. 2009, 55:597-604.
120. Shi L., Wudy S.A., Buyken A.E., Maser-Gluth C., Hartmann M.F., Remer T. Prepubertal glucocorticoid status and pubertal timing. J. Clin. Endocrinol. Metab. 2011, 96:E891-E898.
121. Shirtcliff E.A., Allison A.L., Armstrong J.M., Slattery M.J., Kalin N.H., Essex M.J. Longitudinal stability and developmental properties of salivary cortisol levels and circadian rhythms from childhood to adolescence. Dev. Psychobiol. 2012, 54:493-502.
122. Siever L., Davis K. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Am. J. Psychiatry 2004, 161:398-413.
123. Sisk C., Zehr J. Pubertal hormones organize the adolescent brain and behavior. Front. Neuroendocrinol. 2005, 26:163-174.
124. Smieskova R., Fusar-Poli P., Allen P., Bendfeldt K., Stieglitz R.D., Drewe J., Radue E.W., McGuire P.K., Riecher-Rossler A., Borgwardt S.J. Neuroimaging predictors of transition to psychosis-a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 2010, 34:1207-1222.
125. Sowell E.R., Thompson P.M., Holmes C.J., Batth R., Jernigan T.L., Toga A.W. Localizing age-related changes in brain structure between childhood and adolescence using statistical parametric mapping. Neuroimage 1999, 9:587-597.
126. Sowell E.R., Thompson P.M., Tessner K.D., Toga A.W. Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: inverse relationships during postadolescent brain maturation. J. Neurosci. 2001, 21:8819-8829.
127. Spear L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000, 24:417-463.
128. Steen N.E., Methlie P., Lorentzen S., Hope S., Barrett E.A., Larsson S., Mork E., Almas B., Lovas K., Agartz I., Melle I., Berg J.P., Andreassen O.A. Increased systemic cortisol metabolism in patients with schizophrenia and bipolar disorder: a mechanism for increased stress vulnerability?. J. Clin. Psychiatry 2011, 72:1515-1521.
129. Stetler C., Miller G.E. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom. Med. 2011, 73:114-126.
130. Stroud L.R., Foster E., Papandonatos G.D., Handwerger K., Granger D.A., Kivlighan K.T., Niaura R. Stress response and the adolescent transition: performance versus peer rejection stressors. Dev. Psychopathol. 2009, 21:47-68.
131. Susman E.J., Dorn L.D. Puberty: Its Role in Development, Handbook of Adolescent Psychology 2009, 116-151. John Wiley & Sons, Inc., New York, NY.
132. Suzuki M., Zhou S.Y., Hagino H., Niu L., Takahashi T., Kawasaki Y., Matsui M., Seto H., Ono T., Kurachi M. Morphological brain changes associated with Schneider's first-rank symptoms in schizophrenia: a MRI study. Psychol. Med. 2005, 35:549-560.
133. Takahashi T., Wood S.J., Yung A.R., Soulsby B., McGorry P.D., Suzuki M., Kawasaki Y., Phillips L.J., Velakoulis D., Pantelis C. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch. Gen. Psychiatry 2009, 66:366-376.
134. Tan C.O. Anticipatory changes in regional cerebral hemodynamics: a new role for dopamine?. J. Neurophysiol. 2009, 101:2738-2740.
135. Tessner K.D., Walker E.F., Dhruv S.H., Hochman K., Hamann S. The relation of cortisol levels with hippocampus volumes under baseline and challenge conditions. Brain Res. 2007, 1179:70-78.
136. Thompson K.N., Berger G., Phillips L.J., Komesaroff P., Purcell R., McGorry P.D. HPA axis functioning associated with transition to psychosis: combined DEX/CRH test. J. Psychiatr. Res. 2007, 41:446-450.
137. Thompson K.N., Phillips L.J., Komesaroff P., Yuen H.P., Wood S.J., Pantelis C., Velakoulis D., Yung A.R., McGorry P.D. Stress and HPA-axis functioning in young people at ultra high risk for psychosis. J. Psychiatr. Res. 2007, 41:561-569.
138. van Haren N.E., Picchioni M.M., McDonald C., Marshall N., Davis N., Ribchester T., Hulshoff Pol H.E., Sharma T., Sham P., Kahn R.S., Murray R. A controlled study of brain structure in monozygotic twins concordant and discordant for schizophrenia. Biol. Psychiatry 2004, 56:454-461.
139. Van Leijenhorst L., Gunther Moor B., Op de Macks Z.A., Rombouts S.A., Westenberg P.M., Crone E.A. Adolescent risky decision-making: neurocognitive development of reward and control regions. Neuroimage 2010, 51:345-355.
140. van Rijn S., Aleman A., de Sonneville L., Sprong M., Ziermans T., Schothorst P., van Engeland H., Swaab H. Neuroendocrine markers of high risk for psychosis: salivary testosterone in adolescent boys with prodromal symptoms. Psychol. Med. 2011, 41:1815-1822.
141. van Wingen G.A., Ossewaarde L., Backstrom T., Hermans E.J., Fernandez G. Gonadal hormone regulation of the emotion circuitry in humans. Neuroscience 2011, 191:38-45.
142. Viau V. Functional cross-talk between the hypothalamic-pituitary-gonadal and -adrenal axes. J. Neuroendocrinol. 2002, 14:506-513.
143. Vigil P., Orellana R.F., Cortes M.E., Molina C.T., Switzer B.E., Klaus H. Endocrine modulation of the adolescent brain: a review. J. Pediatr. Adolesc. Gynecol. 2011, 24:330-337.
144. Walker E. Developmentally moderated expressions of the neuropathology underlying schizophrenia. Schizophr. Bull. 1994, 20:453-480.
145. Walker E., Bollini A.M. Pubertal neurodevelopment and the emergence of psychotic symptoms. Schizophr. Res. 2002, 54:17-23.
146. Walker E., Diforio D. Schizophrenia: a neural diathesis-stress model. Psychol. Rev. 1997, 104:667-685.
147. Walker E.F., Grimes K.E., Davis D.M., Smith A.J. Childhood precursors of schizophrenia: facial expressions of emotion. Am. J. Psychiatry 1993, 150:1654-1660.
148. Walker E., Walder D., Reynolds F. Developmental changes in cortisol secretion in normal and at-risk youth. Dev. Psychopathol. 2001, 13:721-732.
149. Walker E., Mittal V., Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu. Rev. Clin. Psychol. 2008, 4:189-216.
150. Walker E.F., Brennan P.A., Esterberg M., Brasfield J., Pearce B., Compton M.T. Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth. J. Abnorm. Psychol. 2010, 119:401-408.
151. Walker, E.F., Trotman, H.D., Pearce, B.D., Addington, J., Cadenhead, K.S., Cornblatt, B.A., Heinssen, R., Mathalon, D.H., Perkins, D.O., Seidman, L.J., Tsuang, M.T., Cannon, T.D., McGlashan, T.H., Woods, S.W., in press. Cortisol levels and risk for psychosis: initial findings from the North American Longitudinal Study. Biological Psychiatry.
152. Weinstein D.D., Diforio D., Schiffman J., Walker E., Bonsall R. Minor physical anomalies, dermatoglyphic asymmetries, and cortisol levels in adolescents with schizotypal personality disorder. Am. J. Psychiatry 1999, 156:617-623.
153. Whitford T.J., Kubicki M., Shenton M.E. Diffusion tensor imaging, structural connectivity, and schizophrenia. Schizophr. Res. Treat. 2011, 2011:709523.
154. Winterer G. Cortical microcircuits in schizophrenia-the dopamine hypothesis revisited. Pharmacopsychiatry 2006, 39(Suppl. 1):S68-S71.
155. Witthaus H., Kaufmann C., Bohner G., Ozgurdal S., Gudlowski Y., Gallinat J., Ruhrmann S., Brune M., Heinz A., Klingebiel R., Juckel G. Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls. Psychiatry Res. 2009, 173:163-169.
156. Wu E.Q., Birnbaum H.G., Shi L., Ball D.E., Kessler R.C., Moulis M., Aggarwal J. The economic burden of schizophrenia in the United States in 2002. J. Clin. Psychiatry 2005, 66:1122-1129.
157. Yates M.A., Juraska J.M. Pubertal ovarian hormone exposure reduces the number of myelinated axons in the splenium of the rat corpus callosum. Exp. Neurol. 2008, 209:284-287.
158. Yildirim O., Dogan O., Semiz M., Kilicli F. Serum cortisol and dehydroepiandrosterone-sulfate levels in schizophrenic patients and their first-degree relatives. Psychiatry Clin. Neurosci. 2011, 65:584-591.
159. Yung A.R., McGorry P.D. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust. N. Z. J. Psychiatry 1996, 30:587-599.
160. Yung A.R., McGorry P.D. Prediction of psychosis: setting the stage. Br. J. Psychiatry Suppl. 2007, 51:s1-s8.
161. Yung A., Phillips L., Yuen H., McGorry P. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 2004, 67:131-142.
162. Yung A.R., Stanford C., Cosgrave E., Killackey E., Phillips L., Nelson B., McGorry P.D. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr. Res. 2006, 84:57-66.